Page last updated: 2024-10-24

bupivacaine and Heart Septal Defects, Ventricular

bupivacaine has been researched along with Heart Septal Defects, Ventricular in 1 studies

Bupivacaine: A widely used local anesthetic agent.
1-butyl-N-(2,6-dimethylphenyl)piperidine-2-carboxamide : A piperidinecarboxamide obtained by formal condensation of the carboxy group of N-butylpipecolic acid with the amino group of 2,6-dimethylaniline.
bupivacaine : A racemate composed of equimolar amounts of dextrobupivacaine and levobupivacaine. Used (in the form of its hydrochloride hydrate) as a local anaesthetic.

Heart Septal Defects, Ventricular: Developmental abnormalities in any portion of the VENTRICULAR SEPTUM resulting in abnormal communications between the two lower chambers of the heart. Classification of ventricular septal defects is based on location of the communication, such as perimembranous, inlet, outlet (infundibular), central muscular, marginal muscular, or apical muscular defect.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Stuth, EA1
Berens, RJ1
Staudt, SR1
Robertson, FA1
Scott, JP1
Stucke, AG1
Hoffman, GM1
Troshynski, TJ1
Tweddell, JS1
Zuperku, EJ1

Trials

1 trial available for bupivacaine and Heart Septal Defects, Ventricular

ArticleYear
The effect of caudal vs intravenous morphine on early extubation and postoperative analgesic requirements for stage 2 and 3 single-ventricle palliation: a double blind randomized trial.
    Paediatric anaesthesia, 2011, Volume: 21, Issue:4

    Topics: Airway Management; Analgesics, Opioid; Anesthetics, Local; Bupivacaine; Cardiopulmonary Bypass; Chil

2011